When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding ...
In patients at high bleeding risk who had undergone percutaneous coronary intervention (PCI), 1 month of dual antiplatelet therapy (DAPT) was associated with a similar rate of major adverse cardiac or ...
NEW ORLEANS, LA—The use of intravascular imaging to guide complex PCI is associated with a significantly lower risk of target vessel failure when compared with conventional angiography, according to ...
Please provide your email address to receive an email when new articles are posted on . In a non-prespecified analysis from the GLOBAL LEADERS study, a ticagrelor monotherapy regimen compared with a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with high bleeding risk who underwent ...
Compared with other types of complex PCI, chronic total occlusion (CTO) PCI is less often associated with procedural success and carries a higher risk of complications such as coronary perforation and ...
The benefit of ticagrelor (Brilinta) monotherapy following a short course of dual antiplatelet therapy (DAPT) was upheld in various high-risk populations undergoing percutaneous coronary intervention ...
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients ...
Patients with CKD had twice the risk of target vessel failure after PCI compared with patients without CKD. The benefits of intravascular imaging-guided percutaneous coronary intervention (PCI) extend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results